By employing a retrospective case-control design and utilizing banked human biospecimens, this study aims to investigate whether specific miRNAs are involved in disrupted insulin signaling pathways and the pathophysiology of T2DM. This evidence concerns the gene INS and type 2 diabetes mellitus.